# Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis

> **NCT03609905** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Liaocheng People's Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Ulcerative Colitis (UC)

## Interventions

- **BIOLOGICAL:** Adipose-cord mesenchymal stromal cells (A-MSCs)
- **OTHER:** Conventional drugs

## Key facts

- **NCT ID:** NCT03609905
- **Lead sponsor:** Liaocheng People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-01
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03609905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03609905, "Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03609905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*